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Research suggests that daily cannabis users have impaired memory for past events, 
but it is not clear whether they are also impaired in prospective memory (PM) for future 
events. The present study examined PM in daily cannabis users who were either 
dependent (n = 18) or non-dependent (n = 18), and compared them with non-using 
controls (n = 18). The effect of future event simulation (FES) on PM performance was 
also examined. Participants were matched across groups on age, gender, and highest 
level of education. The virtual week (VW) was used to objectively assess PM abilities, 
both at baseline and following FES. Other measures used were: cannabis use variables, 
immediate and delayed prose recall, phonemic and category fluency, spot-the-word 
test (premorbid intelligence), Beck Depression Inventory, Beck Anxiety Inventory, and a 
measure of schizotypy (Oxford-Liverpool Inventory of Feelings and Experiences: unusual 
experiences subscale). No group differences were found in PM performance on the 
VW, and FES did not improve PM performance in any group. Dependent cannabis 
users scored higher on depression, anxiety, and schizotypy than both other groups 
with non-dependent cannabis users scoring at a similar level to controls. There were 
no group differences in alcohol use. Findings suggest that when carefully matched on 
baseline variables, and not differing in premorbid IQ or alcohol use, young, near-daily 
cannabis users do not differ from non-using controls in PM performance.
Keywords: prospective memory, cannabis, future event simulation, cannabis dependence, addiction
inTrODUcTiOn
Cannabis has consistently been the most commonly consumed illicit drug in the world, with an 
estimated 120–190 million users worldwide (1). Currently, it is increasingly becoming a legal drug 
for medical and/or recreational use in many parts of the globe and its use is increasing (1). Rapid 
changes in the legislation of the drug strengthen the importance of research on the effects of cannabis 
on mental health and cognitive functioning.
Frequent cannabis use has been associated with depression and anxiety (2). Higher rates of depres-
sion and anxiety have been observed in frequent users who are dependent on cannabis compared 
with frequent users who are non-dependent, who score similarly to the general population (3). There 
is also an association between use of high-potency cannabis and psychosis (4).
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One of the most robust acute effects of cannabis is impairment 
of memory (5) and frequent, chronic use of the drug has also 
been associated with significantly poorer memory performance 
(5, 6). However, the majority of evidence on the effects of cannabis 
use on memory focuses on retrospective memory (memory for 
past events). Research into the effects on future-based memory 
processes remains relatively neglected.
Prospective memory (PM) is a vital aspect of everyday 
memory and refers to the ability to enact intended actions at an 
appropriate moment in the future (7). To-be-remembered actions 
can be event-based (e.g., collecting a prescription when passing 
a doctor’s surgery), time-based (e.g., meeting a friend at 18:00), 
or activity-based (e.g., calling your sister after posting a letter). 
As such, these forms of PM depend, respectively, on whether the 
cue for PM performance is the appearance of a certain stimulus, 
the passage of a certain amount of time or the completion of an 
activity. Actions may also be regular (e.g., taking medication 
every morning), or irregular, one-off or infrequent actions (e.g., 
attending a dentist appointment). PM ability relies on retrospec-
tive memory to retain knowledge of the intention and the cue, and 
on executive planning and motivation functions to coordinate 
intended actions (8).
Impairments in PM performance have been reported among 
individuals with alcohol dependence (9), methamphetamine 
users (10), long-term opiate users (11), heavy social drinkers (12), 
and MDMA users (13). Aside from the adverse consequences 
of PM deficits on everyday functioning, such deficits may also 
specifically impair an individual’s ability to apply planned relapse 
prevention strategies when aiming to curtail substance use. An 
improved understanding of PM in individuals with substance 
dependence might thus help to inform treatment delivery during 
rehabilitation.
There is evidence that deficits in PM can be overcome by 
planned cognitive strategies such as future event simulation (FES). 
FES involves “pre-experiencing” future events using structured 
mental imagery (14) whereby the individual is asked to vividly 
imagine performing the future action during encoding. The con-
structive episodic simulation hypothesis proposes that episodic 
memory combines the details of past experiences (e.g., objects, 
people, and locations) to depict potential future events (14). 
There is some evidence that FES may improve PM performance 
on a widely used, objective measure of PM, the virtual week [VW 
(15)]. A double-blind placebo-controlled trial found that acute 
alcohol induced deficits in event-based PM in healthy individuals 
were overcome by FES (16). Similarly, FES significantly improved 
the performance of heavy social drinkers on event-based tasks 
on the VW (12). However, a study comparing VW performance 
in alcohol-dependent individuals and social drinkers found FES 
improved time-based PM only for the latter (9).
Studies investigating the effects of cannabis use on PM 
performance have found that users perform significantly worse 
than healthy controls on irregular event-based PM tasks (17–
22), and on irregular time-based tasks (19–21, 23). However, 
effect sizes in these studies varied markedly, as did important 
aspects of the PM task used. There was also large variation in 
how a “cannabis user” was defined, ranging from minimal use 
of “some cannabis use in the past year” (17) to “at least four 
times in the last month” (22). Cannabis users and controls were 
also generally poorly matched on other drug use (especially of 
the classic amnesic drug, alcohol) and demographic variables, 
including educational level. Furthermore, no study to date has 
investigated whether deficits in cannabis users’ PM performance 
could be overcome by FES.
The present study therefore sought to determine whether 
individuals who used cannabis on a frequent basis (≥4  days/
week) and fulfilled criteria for dependence or not differed from 
each other and from a control group on the VW. It also aimed 
to see if FES improved PM performance in the three groups 
(control non-users, dependent, and non-dependent daily users). 
In line with previous research, we hypothesised that cannabis 
users would exhibit a deficit in irregular event- and time-based 
PM compared with control participants, with dependent users 
showing a greater irregular PM deficit than non-dependent users. 
We also hypothesised that there would be poorer performance on 
regular PM in cannabis users compared with control participants. 
As no previous study had used FES with cannabis users, this 
aspect was exploratory.
Given the role of memory and executive function in PM 
processes, these domains of cognition were also assessed along 
with depression, anxiety, and schizotypy (“psychosis-proneness”) 
as depression and anxiety are higher only in dependent frequent 
users of cannabis (3).
MaTerials anD MeThODs
Participants and Design
An independent group design was used with 56 participants: 
18 dependent cannabis users, 18 non-dependent cannabis 
users, and 18 non-cannabis using controls. Participants were 
recruited via advertisements at local university campuses and 
around public areas, and on social media websites. Interested 
individuals were telephone screened for eligibility. The inclu-
sion requirement for cannabis users was to use at least 4 days 
per week (i.e., more days than not). Additional information 
during the telephone screening included age at which partici-
pants started using cannabis, number of grams used per week, 
and score on the five-item severity of dependence scale [SDS; 
(24)]. We classified users as dependent (score ≥3 on the SDS) 
or non-dependent (score <3). According to Swift et  al. (25), 
an SDS score of three or above indicates probable cannabis 
dependence, with sensitivity of 64% and specificity of 82% 
when compared with the “gold standard” diagnostic criteria 
for cannabis dependence (DSM-III-IR). All participants were 
required to have limited other illicit drug use (twice a month or 
less) and no history of substance dependence. Potential controls 
were also considered ineligible if they had a history of frequent 
cannabis use (twice a month or more).
Demographic information was collected for all individuals 
including age, gender, and highest level of education. We also asked 
all individuals about their alcohol use and use of other drugs. All 
participants were required to speak English fluently. Exclusion 
criteria included: being under 16 years old, a current or historical 
diagnosis of dependence on any substance other than cannabis 
FigUre 1 | Preparations of cannabis.
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or tobacco, weekly alcohol consumption exceeding 21 units for 
women or 28 units for men, a history of traumatic brain injury or 
stroke, a current or recent (last 3 weeks) experience of psychosis, 
in current treatment (psychological therapy or pharmacological) 
for a mental health problem other than anxiety or depression, a 
diagnosis of a learning disability, reading difficulties, or current 
use of antipsychotic medication or benzodiazepines.
All participants verbally agreed to refrain from consuming 
any illicit drugs and alcohol on the day of the testing session. 
Participants from each of the three groups (dependent cannabis 
users, non-dependent cannabis users, and controls) were actively 
selected to match each other in age, gender, and highest level 
of education as closely as possible. The study received ethical 
approval from the University College London (UCL) Research 
Ethics Committee (5402/001) and all participants provided writ-
ten informed consent prior to taking part.
Measures
Prospective Memory
The VW (15) is a virtual board game that requires participants to 
move a counter around a board (displayed on a laptop screen) by 
rolling an electronic die. Participants work their way around the 
board, with one circuit of the board representing one virtual “day.” 
The virtual time of day is shown on a clock in the centre of the 
board and the time passes as the counter moves around the board. 
Over the virtual day, there are 10 green “E” squares on the board 
to pass through. When a participant’s counter falls on or passes an 
“E” square, they are instructed to click on the event card button 
on the board. This event card symbolises a time-appropriate event 
occurring in the virtual day. For example, the first event cards 
depict morning activities such as eating breakfast, and the last 
event cards depict evening activities such as eating dinner. Each 
event card requires the participant to select a multiple-choice 
answer in response to a given activity, such as what to eat for 
breakfast. Throughout each virtual day, participants are assigned 
a number of tasks they must remember to perform at points later 
in the day (as a measure of PM). In the version of the VW used 
in this study, each day contained four “time-based” tasks to be 
performed at specified times of day (as displayed on the central 
24-h clock), and four “event-based” tasks to be performed in 
response to particular events.
Episodic Memory
The story recall subtest of the Rivermead Behavioural Memory 
Test (26) was used as a measure of verbal episodic memory. 
Participants listen to a short passage of prose and are asked to 
immediately repeat back everything they can remember. They 
then repeat the recall task after a delay. Scoring was standard.
Executive Function
Three verbal fluency tasks were used: phonemic (words begin-
ning with the letter “g”), category (vegetables), and drug fluency 
(alcohol-related words). In addition, the two cannabis using 
groups completed a cannabis-fluency cannabis-related words. 
Participants had 60  s to name as many words relating to each 
category as they could. The three main tasks were counterbal-
anced by topic.
Premorbid Intelligence
The spot-the-word test [STWT; (27)], a task requiring partici-
pants to select the real word from each of 60 letter-string pairs 
containing one word and one non-word, was used as an estimate 
of premorbid intelligence. The STWT has previously demon-
strated convergent validity with the Wechsler Adult Intelligence 
Scale (28).
Cannabis Use
Using an in-house tool, participants were asked to select one of 
three pictures (see Figure 1) that best represents the type of can-
nabis they use most frequently, and to then estimate the approxi-
mate percentage of time they use each of the three types. Each 
picture shows different preparations of cannabis: high-potency 
floral preparation which typically contains very high levels of 
tetrahydrocannabinol (THC) and little or no cannabidiol (CBD), 
often referred to as “skunk” (Figure  1A), compressed resin 
or “hash,” typically containing higher levels of CBD and lower 
levels of THC (Figure 1B) and traditional dried herbal material, 
referred to as “bush weed” or “Thai weed,” which contains much 
lower levels of THC but little or no CBD (Figure 1C).
Depression, Anxiety, and Schizotypy
The Beck Anxiety Inventory [BAI; (29)] and Beck Depression 
Inventory [BDI-II; (30)] were used to assess anxiety and 
depression. The Oxford-Liverpool Inventory of Feelings and 
Experiences [O-LIFE; (31)] is a measure of schizotypy, or 
“psychosis-proneness.” The unusual experiences subscale only 
was used as it has been found to be a reliable and time-efficient 
scale to explore psychosis-proneness (32).
Procedure
All participants attended a one-off testing session at the Clinical 
Psychopharmacology Unit at UCL, which lasted approximately 
2.5 h including breaks. Participants were compensated for their 
time.
Participants from both cannabis groups first completed 
questions about the type of cannabis they used. All participants 
were then introduced to the VW. A trial day was completed to 
orient participants to the task, during which they followed the 
instructions on-screen and had an opportunity to ask questions. 
Participants were not permitted to start the VW until they could 
successfully articulate all of the regular PM tasks to ensure they 
had encoded the information. They were also asked to read aloud 
every event card in the game. Participants then completed their 
first two virtual days. The tester did not provide feedback on 
accuracy.
Recruitment
Via flyers, posters & 
snowball sampling 
Telephone Screening
Eligibility criteria checked
SDS for cannabis participants
Informed Consent
Information sheet discussed with an
opportunity to ask questions 
Talk through and sign consent form
Testing Part 1
Cannabis Use Questionnaire
Instructions and trial day of VW
Two days of VW:
- 4 x event-based regular tasks
- 4 x time-based regular tasks 
- 4 x event-based irregular tasks
- 4 x time-based irregular tasks
10-minute Break
Testing Part 2
FES instructions and practice
Two more days of VW:
- 4 x event-based regular tasks
- 4 x time-based regular tasks 
- 4 x event-based irregular tasks (with FES)
- 4 x time-based irregular tasks (with FES) 
Testing Part 3
Story Recall (immediate)
Spot-the-Word 
Fluency tasks
Story Recall (delayed) 
BDI-II
BAI 
OLIFE
5-minute Break
Debrief
18 Controls 
18 Dependent 
Cannabis Users 
14 Not Eligible
18 Non-Dependent 
Cannabis Users 
22 Controls Screened 50 Cannabis Users 
Screened 
4 Not Eligible
FigUre 2 | Study flow diagram.
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After a 10-min break, participants were instructed on the 
use of the imagery technique (FES) which they were told to 
use when forming intentions related to all irregular events 
presented over the next two virtual days of the VW. This 
involved imagining oneself performing a task in as much 
detail as possible, including details like the setting and course 
of events, the time of day, and the people and objects in the 
scene. Participants were encouraged to set the imagined event 
in their own daily life (e.g., imagining themselves shopping in 
their regular supermarket if given the task of buying groceries). 
Participants then carried out two more days of the VW, during 
which they were prompted by the tester to imagine each irregu-
lar task for 10-s after the task had been set. As such, 2 days of 
the VW were completed without FES, followed by 2 days with 
FES, Participants were then given a 5-min break, after which 
the remaining tasks were administered. Figure 2 shows the full 
study protocol. Note, this study was part of a larger study on 
future thinking in cannabis users. An additional task involved 
imagining various consummatory behaviours, which will be 
reported separately.
statistical analyses
Analyses were primarily performed on IBM SPSS Statistics 
Version 22. A confirmatory Bayesian analysis employed the JASP 
programme Version 0.8.1.2 (33). There was no missing data. 
Variables were visually and statistically checked for normality. 
Table 1 | Group demographics, alcohol use, and spot-the-word scores across 
the dependent cannabis, non-dependent cannabis, and control groups.
Dependent 
cannabis users 
(n = 18)
non-dependent 
cannabis users 
(n = 18)
controls 
(n = 18)
n(%) n(%) n(%)
Gender
Male 9 (50) 10 (55.6) 6 (33.3)
Female 9 (50) 8 (44.4) 12 (66.8)
Highest level of education
GCSE or vocational 
qualification
1 (5.6) 2 (11.1) 3 (16.7)
A level 8 (44.4) 5 (27.8) 5 (27.8)
University degree 9 (50.0) 11 (61.1) 10 (55.6)
M (sD) M (sD) M (sD)
Age (years) 24.2 (5.1) 23.9 (3.7) 23.4 (3.7)
Spot-the-word score 49.5 (3.5) 47.2 (5.8) 48.6 (5.3)
Alcohol (units consumed 
per week)
10.1 (8.1) 9.8 (6.9) 11.0 (8.8)
Table 2 | Cannabis use in the cannabis groups.
Dependent cannabis 
users (n = 18)
non-dependent 
cannabis users (n = 18)
n(%) n(%)
Type of cannabis most commonly used
Picture A—“Skunk” 15 (83.3) 17 (94.4)
Picture B—“Hash” 0 1 (5.6)
Picture C—“Herbal” 3 (16.7) 0
Median (iQr) Median (iQr)
Frequency of use of each cannabis type (%)
Picture A—“Skunk” 80.5 (23) 85.0 (28)
Picture B—“Hash” 10 (13) 7 (16)
Picture C—“Herbal” 8 (23) 0.5 (10)
Amount used a week  
(grams)
5 (4.75) 4 (4.63)
M (sD) M (sD)
Days used per week 6.5 (0.7) 6.06 (1.3)
Age started using cannabis 15.6 (2.2) 16.1 (1.9)
SDS Score*** 4.3 (1.5) 0.8 (0.8)
***p < 0.001, **p < 0.01, *p < 0.05.
Table 3 | Episodic memory and executive functioning in dependent cannabis, 
non-dependent cannabis, and control groups.
Dependent 
cannabis 
users (n = 18)
non-dependent 
cannabis users 
(n = 18)
controls 
(n = 18)
M (sD) M (sD) M (sD)
Episodic memory
Story recall—immediate 7.3 (2.5) 7.5 (2.7) 8.9 (3.1)
Story recall—delayed 6.5 (2.2) 6.3 (2.4) 7.6 (3.2)
Executive functioning
Phonemic fluency—letter 14.8 (5.8) 12.0 (3.7) 15.1 (4.5)
Category fluency—“vegetables” 15.6 (5.1) 13.6 (4.6) 15.9 (4.6)
Category fluency—“alcohol” 20.5 (7.6) 19.3 (4.9) 21.7 (8.8)
Category fluency—“cannabis” 20.8 (7.8) 21.3 (7.7) –
5
Braidwood et al. Prospective Memory in Cannabis Users
Frontiers in Psychiatry | www.frontiersin.org March 2018 | Volume 9 | Article 97
Means and SDs were reported where parametric statistical tests 
were employed. Taking sample size into consideration (34), 
skewness, and kurtosis Z-scores of ≥3.29 were used to identify 
non-normality. Using this criterion, frequency of type of cannabis 
used as a percentage of all occasions, amount of cannabis (grams 
per week), and the BAI data violated assumptions of normality. 
For non-normal variables measured in only two groups (i.e., 
cannabis-related variables), non-parametric (Mann–Whitney U 
tests) were used to compare groups and central tendency and dis-
persion were described using medians and inter-quartile ranges. 
For all other variables, parametric χ2 tests were used to compare 
categorical variables, and t-tests (two group comparisons) or 
ANOVAs (three group comparisons) were used to detect group 
differences for continuous data.
The assumption of homogeneity of variance (as evidenced by 
Levene’s test) and normality according to our criteria (Z ≤ 3.29) 
was met for all VW variables. VW data were analysed with 
repeated measures ANOVAs, with Bonferroni-adjusted pairwise 
comparisons performed to explore post  hoc effects. To explore 
relationships between significant variables, Spearman’s rho (rs) 
correlations were conducted (on both parametric and non-par-
ametric variables, to allow for direct comparison). Correlations 
were conducted with an adjusted alpha of 0.01 to minimise 
Type-I error. Data were also examined for extreme values. One 
participant’s score in one of the VW variables was four SDs from 
the mean, and was Winsorised to the next highest non-outlying 
value.
resUlTs
group Demographics
There were no differences between the groups in terms of gender, 
χ2 (2, N = 54) = 1.94, p = 0.38, age, F(2, 51) = 0.15, p = 0.89, highest 
level of education, χ2 (4, N = 54) = 2.20, p = 0.67, spot-the-word 
score, F(2, 51) = 1.00, p = 0.37, or units of alcohol consumed per 
week, F(2, 51) = 0.12, p = 0.89 (Table 1).
cannabis Use
There were no differences between dependent and non-dependent 
cannabis users in the type of cannabis most commonly used, with 
both groups primarily using high-potency skunk (Table 2). There 
were no differences between cannabis groups in: the frequency 
that each preparation of cannabis was used as a percentage of 
total cannabis use occasions, for skunk, U = 141, p = 0.52, herbal 
preparations, U = 132.5, p = 0.36, and hash, U = 156.5, p = 0.86; 
mean age of onset of cannabis use, t(34) = 6.48, p = 0.52; amount 
of cannabis (grams) used a week, U =  152.5, p =  0.77; or the 
number of days of cannabis use/week, t(34) = 1.31, p = 0.2.
The mean SDS score in the dependent group was 4.3 (±1.5), 
significantly higher than in the non-dependent group: 0.8 [±0.8; 
t(34) = 8.60, p < 0.001].
episodic Memory and executive Function
There were no group differences in immediate [F(2, 51) = 1.89, 
p =  0.16], or delayed [F(2, 51) =  1.39, p =  0.26] story recall 
(Table  3). There were also no group differences on measures 
FigUre 3 | Mean (SE) scores for the BDI-II (depression), BAI (anxiety), and O-life unusual experiences (schizotypy) in the dependent cannabis, non-dependent 
cannabis, and control groups.
Table 4 | Depression, anxiety, and schizotypy in dependent cannabis, non-
dependent cannabis, and control groups.
Dependent 
cannabis users 
(n = 18)
non-dependent 
cannabis users 
(n = 18)
controls 
(n = 18)
M (sD) M (sD) M (sD)
Depression
BDI-II total score*** 11.2 (4.9) 2.9 (3.6) 5.5 (5.1)
Anxiety
BAI total score*** 9.9 (6.3) 3.0 (3.6) 4.6 (4.5)
Schizotypy
O-LIFE—unusual 
experiences***
5.1 (2.4) 2.1 (2.8) 1.6 (1.6)
 ***p < 0.001, **p < 0.01, *p < 0.05.
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of executive functioning: phonemic fluency [F(2, 51) =  2.28, 
p = 0.11], category fluency [F(2, 51) = 1.27, p = 0.29], and alcohol 
fluency [F(2, 51) = 0.48, p = 0.62]. The two cannabis using groups 
did not differ in fluency of use [t(34) = 0.193, p = 0.85].
Depression, anxiety, and schizotypy
There were group differences in depression, anxiety, and schizo-
typy as measured by the BDI-II, F(2, 51) = 15.6, p < 0.001, BAI, 
F(2, 51) = 9.89, p < 0.001, and O-LIFE unusual experiences, F(2, 
51) = 11.65, p < 0.001 (Table 4; Figure 3). Bonferroni-adjusted 
pairwise comparisons indicated that the dependent cannabis 
group had significantly higher levels of depression, anxiety, and 
schizotypy than both the non-dependent group (p < 0.001) and 
controls (p ≤ p = 0.006). The control group and non-dependent 
group did not significantly differ on depression (p = 0.28), anxiety 
(p = 1.0), or schizotypy (p = 1.0). According to BDI-II scores, 33% 
of dependent cannabis users were mildly depressed (BDI scores: 
14–19), compared with 5.6% of both the non-dependent cannabis 
users and control group.
Pre-Fes VW
The data from the pre-FES VW days (the first virtual 2 days prior 
to use of FES) were first analysed to assess any baseline group 
differences in PM performance (Table 5). The dependent vari-
able was the proportion of tasks that were completed correctly 
and analysed using a 2 × 2 × 3 repeated measures ANOVA with 
the within-subjects factors of task regularity (irregular, regular), 
task cue (event-based, time-based), and between-subjects fac-
tor of group (dependent cannabis, non-dependent cannabis, 
and controls). There was a significant main effect of task cue, 
F(1, 51) = 10.07, p = 0.003, with Bonferroni-adjusted pairwise 
comparisons indicating that the proportion of correct responses 
was greater on event-related tasks (M = 0.82, SD = 0.19) than 
time-related (M = 0.72, SD = 0.25).
There was no main effect of task regularity, F(1, 51) = 0.39, 
p  =  0.845, or interaction between group and task cue, F(1, 
51) = 1.07, p = 0.352, group and task regularity, F(1, 51) = 2.68, 
p = 0.078, cue and task regularity, F(1, 51) = 3.403, p = 0.071, 
or a three-way interaction between task regularity, task cue, and 
group, F(1, 51) = 0.093, p = 0.912. The outcome of a Bayesian 
ANOVA (BF01 = 4.15) was consistent with the standard analysis, 
indicating “moderate” evidence (35) for the null hypothesis, an 
absence of a three-way interaction.
VW With Fes
To assess the impact of FES on PM performance, the proportion 
of irregular VW tasks completed correctly before the introduc-
tion of FES was compared with the FES condition. This was done 
for event-based tasks and time-based tasks separately, with two 
2 × 3 repeated measures ANOVAs with the within subject fac-
tors of imagining (no FES, FES) and the between-subjects factor 
of group (dependent cannabis, non-dependent cannabis, and 
controls).
For event-based irregular tasks, there was no main effect of 
FES, F(1, 51) = 1.98, p = 0.165, nor an interaction between FES 
Table 5 | Comparison of dependent cannabis, non-dependent cannabis, and 
control groups on mean (SD) proportion of irregular and regular prospective 
memory (PM) tasks completed correctly in the prefuture event simulation virtual 
week.
PM task Dependent  
cannabis users 
(n = 18)
non-dependent 
cannabis users 
(n = 18)
controls 
(n = 18)
M (sD) M (sD) M (sD)
Irregular
Event-based 0.82 (0.17) 0.86 (0.21) 0.85 (0.23)
Time-based 0.61 (0.31) 0.78 (0.21) 0.69 (0.33)
Regular
Event-based 0.88 (0.15) 0.74 (0.25) 0.75 (0.34)
Time-based 0.76 (0.28) 0.72 (0.28) 0.72 (0.36)
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condition (FES; no FES) and group, F(1, 51) = 0.258, p = 0.774. 
Similarly, for time-based irregular tasks there was no main effect 
of FES condition, F(1, 51) = 0.337, p = 0.564, nor an interaction 
between FES and group, F(1, 51) = 0.861, p = 0.429. Bayes Factor 
ANOVAs indicated “moderate” evidence (35) for the null hypoth-
eses for both the event-based irregular task ANOVA (BF01 = 5.6) 
and the time-based ANOVA (BF01 = 3.65).
correlations
Exploratory analyses examined the extent of association between 
cognitive task performance with intellectual functioning (spot-
the-word score) and amount of cannabis use (grams per week). 
PM (overall proportion correct on the VW), episodic memory 
(immediate and delayed story recall), and executive function-
ing (average fluency score) were correlated with spot-the-word 
score for all groups, and also with amount of cannabis used for 
the cannabis groups. Specifically, there was a strong positive 
correlation in non-dependent cannabis users between STW 
score and immediate episodic memory (rs = 0.69, p = 0.002). 
Across all three groups there were strong positive correlations 
between delayed episodic memory and STW score (dependent 
cannabis users: rs =  0.57, p =  0.01; non-dependent cannabis 
users: rs = 0.6, p = 0.008; controls: rs = 0.51, p = 0.03). No other 
correlations were significant.
DiscUssiOn
Key Findings
Summary
This is the first study to examine PM (regular, irregular, time-, 
and event-based) and the effects of FES on PM ability in 
dependent and non-dependent daily cannabis users compared 
with non-using controls. Critically, the three groups were well-
matched on key variables including age, premorbid intelligence, 
education level, and weekly alcohol consumption. Importantly, 
the two cannabis using groups did not differ in any index of 
cannabis use (age of first use, years used, frequency of use per 
week, amount used per  session, and type of cannabis used). 
However, they did differ significantly in cannabis dependence, 
with SDS scores in the dependent group being more than five 
times greater than that of the non-dependent group.
There were no differences between groups in PM ability. The 
use of a strategy that required participants to mentally rehearse 
tasks—FES—did not lead to improvements in PM scores. All 
groups scored similarly on measures of episodic memory and 
executive functioning (fluency tasks).
In terms of mental health, dependent cannabis users scored 
higher than non-dependent users and non-using controls on 
depression, with 33% falling into the category for “mild depres-
sion” on the BDI-II compared with just 6% in each of the other 
two groups. Dependent cannabis users also scored higher on 
anxiety and schizotypy than both the non-dependent and control 
group. We therefore replicated the findings of van der Pol et al. (3) 
that dependent cannabis users are more depressed and anxious 
than non-dependent users. It has previously been found that can-
nabis users score higher than non-users on schizotypy but this is 
the first finding that dependent cannabis users specifically have 
higher scores than non-dependent, suggesting previous findings 
may have been due to the inclusion of dependent users among 
the sample of users.
Effect of Cannabis Use on PM
Some previous research indicates that people who use cannabis 
perform more poorly on tasks of PM than those who do not 
(17–23). Our findings (across both irregular and regular PM) 
go against this, as we found no differences between near-daily 
users and controls. Indeed, two (out of six) previous PM studies 
with cannabis users employing objective assessments (19, 20) 
measuring irregular event-based PM, and one (out of five) studies 
measuring irregular time-based PM, also did not find differences 
between cannabis users and controls (19). As such, interpreting 
the existing literature is difficult given the broad range of defini-
tions of “cannabis user” used for determining inclusion across 
studies, and differences in measures of PM and other methodo-
logical variations. However, it does appear that in our study, when 
carefully controlling for demographic factors within our sample 
of self-selecting young adults predominantly of high-educational 
status, frequent cannabis use does not adversely affect PM as 
measured by the VW task. Another explanation of our findings 
is that there may be an effect of cannabis use on PM, but that it 
was not detected in this study due to insufficient power (despite 
our a priori power calculation) or validity issues in the VW task.
It is important to consider the characteristics of the sample 
used in our study when interpreting the results on PM. The 
participants were mainly in their 20 s, relatively high functioning 
and well-educated, with 50–60% of each group having at least one 
university degree. Further, the cannabis groups did not differ in 
memory or executive performance relative to the control group, 
which is not consistent with previous studies of frequent cannabis 
users [for a review see Curran et al. (5)]. To test the hypothesis 
that our sample included a cognitively able subgroup of cannabis 
users for whom the cognitive effects of using cannabis are less pro-
nounced (or non-existent), we conducted post hoc correlational 
analyses exploring whether intellectual functioning was driving 
the PM ability in the cannabis groups. These were not consistent 
with this idea. In fact, our analyses were consistent with a large 
meta-analysis (36) which found that years of education did not 
moderate the cognitive effects of cannabis.
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Effect of FES on PM
There were no improvements in PM performance across depend-
ent cannabis users, non-dependent cannabis users, and control 
participants after the introduction of FES. FES has been shown to 
improve some aspects of VW performance in heavy drinkers (12) 
healthy individuals acutely administered alcohol (16), and social 
drinkers but not for those dependent on alcohol (9).
As all three groups showed high levels of performance on the 
VW, it may be that participants were already at a ceiling level of 
performance leaving little room for improvement. The two can-
nabis groups were also more homogeneous than the controls on 
this task, with the controls showing higher variation (SD) across 
all the components of the task than the other two groups. It is also 
possible that FES did not benefit our participants.
According to the constructive episodic simulation hypothesis, 
episodic memory combines the details of past experiences (e.g., 
objects, people, and locations) to depict potential future events 
(14). It could be that the tasks on the VW have no direct relevance 
to participants’ episodic memories (e.g., “telephoning Bill about 
babysitting”), rendering imagining the potential future event a 
difficult task.
Cannabis Use and Mental Health
Cannabis use variables measured in this study did not differ 
between users classified as dependent and those as non-dependent. 
We had anticipated that dependent users would be more likely to 
use higher-THC type cannabis associated with more addiction 
risk and more pronounced memory impairment. However, 83% 
of dependent users and 94% of non-dependent users primarily 
used high-potency cannabis, which is increasingly the most read-
ily available preparation dominating the market (5).
The finding that dependent users scored higher on schizotypy 
yet smoked equally potent cannabis as the non-dependent group 
could indicate this subgroup are affected in a different way by their 
cannabis use. This dependent group may have a pre-existing reac-
tivity to cannabis that renders them more prone to experiencing 
psychotic-like symptoms—or, indeed, these symptoms were pre-
existing and the group were more vulnerable to becoming depend-
ent after starting cannabis use. The dependent cannabis group 
were also more depressed and anxious than non-dependent users, 
indicating that cannabis may be used to self-medicate symptoms 
(37) and highlighting the importance of mental health screening.
limitations and Future research
We cannot generalise beyond the population sample who par-
ticipated in the study—a group of young, relatively well-educated 
almost daily users. We cannot assume the same results would 
emerge in older frequent cannabis users, those with lower 
educational attainment, or those seeking treatment for cannabis 
use disorder.
Future studies aiming to draw causal links between cannabis 
use and PM performance, would need to be prospective, longi-
tudinal studies of individuals before, during and after cessation 
of drug use. Longitudinal studies would also help to determine 
whether frequent cannabis use beyond young adult age would 
lead to PM deficits. In addition, use of ecologically valid measures 
of PM performance outside the laboratory using experience 
sampling methods would help to determine effects of differing 
levels of cannabis use on everyday memory functioning. Urine 
tests would also provide an objective measure of other drug use 
and whether participants refrained from drug use on the day of 
testing, as the present study relied on self-report.
cOnclUsiOn
This study was the first to test daily cannabis users (both dependent 
and non-dependent) on various forms of PM, and compare them to 
non-using controls. When carefully matched on key demographic 
variables, including educational level and alcohol use, and when 
dependent and non-dependent users did not differ on any cannabis 
use variable, we found no evidence for a PM deficit in young adults 
in any group, nor evidence that FES has any effect on performance. 
The two cannabis groups differed significantly in cannabis depend-
ence, and also on scores of depression, anxiety, and schizotypy.
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